Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi

Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi

Bibliographic Details
Main Authors:	Fine, P, Ponnighaus, J, Warndorff, D, Gruer, P, Oxborrow, S, Pharoah, P, Lucas, S, McDougall, A, Jenkins, P, Chavula, D, Msiska, G, Msosa, E, Munthali, M, Mwamondwe, B, Ngoma, D, Nkhosa, P, Phiri, H, Simfukwa, M, Chihana, A, Kawaonja, D, Malema, S, Mwinuka, V, Mkandawire, P, Nyasulu, S, Tegha, H
Format:	Journal article
Published:	1996

Similar Items

Pengaruh vaksinasi BCG terhadap timbulnya cacad pada penderita lepra
by: , DARWIN, Wasil M, et al.
Published: (1992)

Pengaruh vaksinasi BCG terhadap timbulnya cacad pada penderita lepra
by: , DARWIN, Wasil M, et al.
Published: (1992)

Revaccination with BCG: does it work?
by: McShane, H
Published: (2024)

Understanding BCG is the key to improving it.
by: McShane, H
Published: (2013)

Ocular contamination with BCG vaccine.
by: Pollard, A, et al.
Published: (1994)

Efek proteksi vaksinasi BCG terhadap lepra di Daerah Istimewa Yogyakarta dan sekitarnya
by: , BUDIARTHO, Bambang Setio, et al.
Published: (1996)

Efek proteksi vaksinasi BCG terhadap lepra di Daerah Istimewa Yogyakarta dan sekitarnya
by: , BUDIARTHO, Bambang Setio, et al.
Published: (1996)

The humoral immune response to BCG vaccination
by: Tanner, R, et al.
Published: (2019)

An unusual cutaneous complication of BCG immunotherapy
by: Lloyd-Lavery, A, et al.
Published: (2009)

Osteomyelitis of the humerus complicating BCG vaccination.
by: Segal, S, et al.
Published: (2006)

Optimisation of a human BCG challenge model
by: Wilkie, M, et al.
Published: (2015)

BCG: Myths, realities, and the need for alternative vaccine strategies
by: Mcshane, H, et al.
Published: (2012)

BCG: myths, realities, and the need for alternative vaccine strategies.
by: Mcshane, H, et al.
Published: (2012)

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial
by: Satti, I, et al.
Published: (2024)

BCG-induced granuloma formation in murine tissues.
by: Gordon, S, et al.
Published: (1994)

Editorial commentary: Understanding BCG is the key to improving it
by: McShane, H
Published: (2014)

Hubungan antara skar vaksinasi BCG dengan uji PPD dan uji BCG pada siswa sekolah dasar Kotamadya Yogyakarta
by: , AMINAH, Sri, et al.
Published: (1999)

The natural course of a localized BCG vaccine abscess
by: Brummaier, T, et al.
Published: (2019)

The influence of the gut microbiome on BCG-induced trained immunity
by: Stražar, Martin, et al.
Published: (2022)

The influence of the gut microbiome on BCG-induced trained immunity
by: Stražar, Martin, et al.
Published: (2021)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
by: Whelan, K, et al.
Published: (2009)

A dose escalation study to evaluate the safety of an aerosol BCG infection in previously BCG-vaccinated healthy human UK adults
by: Fredsgaard-Jones, T, et al.
Published: (2024)

Detection of apoptosis in human macrophage cell line, THP-1 infected with BCG and recombinant BCG (rBCG) expressing the 19-kDa C-terminus of the Merozoite Surface Protein-1 (MSP-1C)
by: Mei, Cheong Siew
Published: (2013)

Prevention of tuberculosis in macaques after intravenous BCG immunization
by: Darrah, Patricia A., et al.
Published: (2020)

Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG
by: Saubi, N, et al.
Published: (2012)

The role of TLR-2 IN the production of TNF-a and IL-10 by macrophage infected with a recombinant BCG (rBCG) expressing the MSP-1COF Plasmodium falciparum
by: Rajendran, Sasirekha D/O
Published: (2015)

Pro inflammatory responses of thp-1 macrophage cell line infected with recombinant bcg (rBCG) expressing the MSP-1C of Plasmodium falciparum
by: Yen, Pong Sze
Published: (2013)

Vaccination against tuberculosis: how can we better BCG?
by: Pitt, J, et al.
Published: (2013)

B.C.G. vaccination and leukaemia. Evidence of vital statistics.
by: Kinlen, L, et al.
Published: (1971)

T-cell activation is an immune correlate of risk in BCG vaccinated infants
by: Fletcher, H, et al.
Published: (2016)

Vaccination against tuberculosis: How can we better BCG?
by: Pitt, J, et al.
Published: (2013)

Transcriptional profiling of mycobacterial antigen-induced responses in infants vaccinated with BCG at birth
by: Fletcher, H, et al.
Published: (2009)

Immunoregulatory effects of recombinant BCG (rBCG) expressing c-terminus of merozoite surface protein-1 (MSP-1C) of Plasmodium falciparum on mouse macrophage
by: Mohamad, Dhaniah
Published: (2013)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
by: Harris, S, et al.
Published: (2013)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
by: Harris, SA, et al.
Published: (2014)

Characterization of the putative operon containing arylamine N-acetyltransferase (nat) in Mycobacterium bovis BCG.
by: Anderton, M, et al.
Published: (2006)

Suppurative BCG lymphadenitis and the importance of microbiology investigations – a case report
by: Muhamad Damanhur, Fatimahtuz Zahrah, et al.
Published: (2020)

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants.
by: Fletcher, H, et al.
Published: (2016)

Searching for Extreme-BCG Clusters at 0.2 < z < 1.3
by: Somboonpanyakul, Taweewat
Published: (2022)

A cough conundrum in a patient with a previous history of BCG immunotherapy for bladder cancer.
by: Mehta, A, et al.
Published: (2012)